CoverageForm 410-K10-Q8-K13D13G13F

Vaxxinity, Inc.

VAXXCIK 0001851657 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback
Full filing:tone -0.0026

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Top insiders

Most active reporters at Vaxxinity, Inc.

NameRolesFilings
Ogilvie Landon E
Director
1
Ray Sumita
Officer
1
Smith James Alan
Director
1
Toledano Gabrielle B
Director
1

Showing 16-19 of 19

PrevPage 4 of 4

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Vaxxinity, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#InsiderTradesWin rateAvgMedianBestWorst
1Prime Movers Lab Fund I LP25100%+37.7%+50.5%+56.4%+5.7%
2Sloss Dakin25100%+37.7%+50.5%+56.4%+5.7%
3Hu Mei Mei617%-32.4%-40.5%+11.8%-52.9%
4Reese Lou617%-32.4%-40.5%+11.8%-52.9%
5United Biomedical Inc617%-32.4%-40.5%+11.8%-52.9%

All filings

46 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue